Brief: Aptorum Group Announces Completion Of Pre-Ind Discussions With FDA On Its Drug Als-4 Targeting Methicillin Resistant Staphylococcus Aureus

Aptorum

03/03/2023 12:45

March 3 (Reuters) - Aptorum Group Ltd  APM.O :
    * APTORUM GROUP ANNOUNCES COMPLETION OF PRE-IND DISCUSSIONS
WITH
US FDA ON ITS ALS-4, A FIRST-IN-CLASS SMALL MOLECULE DRUG
TARGETING METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS
    * WITH POSITIVE FEEDBACK ON OVERALL DEVELOPMENT STRATEGY
FROM US
FDA, APTORUM IS NOW PROCEEDING TOWARDS IND SUBMISSION OF ALS-4

Source text for Eikon:  ID:nBw1dg9Qba 
Further company coverage:  APM.O